Sarah Cannon Research Institute University of Oklahoma

Oklahoma City, Oklahoma 73104

2 studies enrolling now · 2 studies all time

What they study most

Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Carcinomas (NEC), Neuroendocrine Prostate Cancer (NEPC), Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Small Cell Lung Cancer (SCLC)

Studies at this site

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) — Recruiting now
• Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) — Recruiting now